CareDx, Inc (CDNA)
NASDAQ: CDNA · Real-Time Price · USD
12.11
+0.29 (2.45%)
Aug 15, 2025, 10:58 AM - Market open
CareDx Employees
As of December 31, 2024, CareDx had 650 total employees, including 644 full-time and 6 part-time employees. The number of employees increased by 7 or 1.09% compared to the previous year.
Employees
650
Change (1Y)
7
Growth (1Y)
1.09%
Revenue / Employee
$524,348
Profits / Employee
$89,445
Market Cap
644.58M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 650 | 7 | 1.09% |
| Dec 31, 2023 | 643 | -95 | -12.87% |
| Dec 31, 2022 | 738 | 93 | 14.42% |
| Dec 31, 2021 | 645 | 170 | 35.79% |
| Dec 31, 2020 | 475 | 89 | 23.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CDNA News
- 8 days ago - CareDx, Inc (CDNA) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - CareDx Announces Appointment of Nathan Smith as Chief Financial Officer - Business Wire
- 8 days ago - CareDx Announces Second Quarter 2025 Financial Results - Business Wire
- 8 days ago - CareDx Announces Landmark KOAR Study Published in the American Journal of Transplantation - Business Wire
- 14 days ago - CareDx Announces Landmark Data in AI-Powered Transplant Diagnostics Showcased in Over 40 Abstracts and 16 Oral Presentations at the 2025 World Transplant Congress - Business Wire
- 23 days ago - CareDx to Report Second Quarter 2025 Financial Results - Business Wire
- 4 weeks ago - CareDx Announces Proposed Draft LCD That Affirms Surveillance Testing Coverage for Solid Organ Transplant Rejection - Business Wire
- 2 months ago - CareDx: The Transplant Diagnostics Leader, But Challenges Will Increase On The Road Ahead - Seeking Alpha